| Description |
1 online resource (xvii, 416 pages) : illustrations (some color) |
| Contents |
880-01 Part I. Principles and Technologies -- Theoretical Background of Apheresis Therapy / Norio Hanafusa -- Methods to Remove Pathogens / Tamami Tanaka, Osamu Ichimura, Yugo Nagae and Nobuhiro Sakuma -- Decision to Prescribe PE, DFPP, or PA / Rei Isshiki and Hiroko Yamamoto -- Plasma Exchange / Daisuke Katagiri and Hideo Kurosawa -- Double Filtration Plasmapheresis / Daisuke Katagri and Kana Mogi -- Plasma Adsorption / Yasuyuki Watanabe and Maki Tsukamoto -- Cryofiltration / Daisuke Katagiri and Hiroko Yamamoto -- Double Filtration Plasmapheresis Thermo-Mode (DF Thermo) / Mizuki Yamano -- Plasma Diafiltration / Hajime Nakae -- Direct Plasma Adsorption / Mayumi Miwa and Maki Tsukamoto -- Cytapheresis / Yuki Itoh and Maki Tsukamoto -- Cell-Free and Concentrated Ascites Reinfusion Therapy / Norio Hanafusa -- Part II. Therapeutic Details -- Choice of Apheresis Therapy / Eisei Noiri -- Determination of Dosage and Frequency of Therapy / Norio Hanafusa -- Vascular Access / Koji Okamoto -- Anticoagulants / Tetsushi Yamashita, Toshihiro Torato -- Part III. Complications -- Hypotension / Tsuyoshi Inoue -- Bleeding Complications and Reduction of Coagulation Factors / Norio Hanafusa -- Allergies / Motonobu Nakamura -- Electrolyte Disorders -- Avoiding Complications During Apheresis / Tetsushi Yamashita, Hiroko Yamamoto -- Infections / Osamu Yamazaki -- Part IV. Autoimmune Disorders -- Neurological Diseases / Masao Iwagami, Kousuke Negishi -- Dermatological Disorders / Masao Iwagami, Kousuke Negishi -- Kidney Diseases / Masao Iwagami, Kousuke Negishi -- Rheumatoid Arthritis and Collagen Diseases / Hiroko Kanda -- Blood Type Incompatible Pregnancies / Norio Hanafusa -- Multiple Myeloma / Tsuyoshi Inoue -- Dilated Cardiomyopathy / Yoshifumi Hamasaki -- Part V. Pathogens with Large Molecular Weight -- Low Density Lipoprotein Apheresis / Kenjiro Honda, Kent Doi -- Endotoxin Absorption Therapy / Kent Doi -- Part VI. Diseases Necessary to Supply Coagulation Factors -- Liver Disease / Kent Doi -- Thrombotic Thrombocytopenic Purpura and Thrombotic Microangiopathy / Kenjiro Honda, Kent Doi -- Inflammatory Bowel Diseases / Tsuyoshi Inoue -- Hepatitis C Virus Infection / Shi Lu, Eisei Noiri -- Drug Intoxication / Motonobu Nakamura -- Living Related Kidney Transplantation / Hiroo Kawarazaki -- Peripheral Blood Stem Cell Transplantation / Naoko Watanabe-Okochi -- Part VII. Pediatric Apheresis -- Apheresis in Children / Motoshi Hattori |
|
880-01/(S Machine generated contents note: pt. I Principles and Technologies -- 1. Theoretical Background of Apheresis Therapy / Norio Hanafusa -- 1.1. What Is Apheresis-- 1.2. Properties of Therapies Relating to Removal of Pathogenic Substances -- 1.3. Properties of Removed Substances -- References -- 2. Methods to Remove Pathogens / Nobuhiro Sakuma -- 2.1. Membrane -- 2.2. Adsorption -- 2.3. Centrifugation -- References -- 3. Decision to Prescribe PE, DFPP, or PA / Hiroko Yamamoto -- 3.1. Introduction -- 3.2. Plasmapheresis Modalities -- References -- 4. Plasma Exchange / Hideo Kurosawa -- 4.1. Introduction -- 4.2. Circuit and Preparation -- 4.3. Choice of Replacement Solution -- 4.4. Adverse Effects of FFP Replenishment -- 4.5. Clinical Application of PE -- 4.6. Anticoagulant -- 4.7. Complications of PE -- 4.8. Points to Note -- 5. Double Filtration Plasmapheresis / Kana Mogi -- 5.1. Introduction -- 5.2. Basic Principles of DFPP -- 5.3. Notice During Treatment -- 5.4. Notice at the Completion of Therapy -- 5.5. Adverse Effects -- Reference -- 6. Plasma Adsorption / Maki Tsukamoto -- 6.1. Introduction -- 6.2. Construction of the Dialysis Circuit and Priming -- 6.3. Points to Note -- 6.4. Characteristics of Particular Adsorption Devices and Points to Be Noted -- References -- 7. Cryofiltration / Hiroko Yamamoto -- 7.1. Concept -- 7.2. Treatment of Cryoglobulinemia -- 7.3. Methods -- 7.4. Points to Note -- 7.5. Clinical Effect -- 7.6. Comparison with Other Treatments -- References -- 8. Double Filtration Plasmapheresis Thermo-Mode (DF Thermo) / Mizuki Yamano -- 8.1. Double Filtration Plasmapheresis Thermo-Mode (DF Thermo) -- 8.2. Effect of Warming -- 8.3. Circuit Configuration -- 8.4. Selection of Plasma Component Membrane -- 8.5. Equipment and Features Required for DF Thermo -- 8.6. Setting the Operating Parameters and Monitoring -- 8.7. Replacement Fluid -- 8.8. Indication Diseases, Indicators of Treatment, and Frequency of Therapy -- 8.9. Anticoagulant Therapy -- 8.10. Points to Note -- References -- 9. Plasma Diafiltration / Hajime Nakae -- 9.1. Introduction -- 9.2. PDF Procedures -- 9.3. Options for PDF -- References -- 10. Direct Plasma Adsorption / Maki Tsukamoto -- 10.1. Direct Plasma Adsorption -- 10.2. Important Principles for Hemoperfusion -- 10.3. Carbon Adsorption -- 10.4. Endotoxin Adsorption (PMX-DHP) -- 10.5. β2 Microglobulin Adsorption -- 11. Cytapheresis / Maki Tsukamoto -- 11.1. Types of Cytapheresis -- 11.2. Efficacy and Side Effects -- 11.3. Priming -- 11.4. Vascular Access -- 11.5. Anticoagulant -- 11.6. Points to Note -- References -- 12. Cell-Free and Concentrated Ascites Reinfusion Therapy / Norio Hanafusa -- 12.1. Concepts -- 12.2. Scope of Patients -- 12.3. Methods -- 12.4. Operation Methods -- 12.5. Clinical Benefits -- 12.6. Adverse Events -- References -- pt. II Therapeutic Details -- 13. Choice of Apheresis Therapy / Eisei Noiri -- 13.1. Introduction -- 13.2. Way of Thinking of Prescribing Apheresis for Disorders -- 13.3. Summary -- 14. Determination of Dosage and Frequency of Therapy / Norio Hanafusa -- 14.1. Introduction -- 14.2. IgG Removal -- 14.3. Selection of Dosage Prescription -- References -- 15. Vascular Access / Koji Okamoto -- 15.1. Blood Access -- 15.2. Pre-existing Blood Access During Apheresis -- 15.3. Direct Puncture -- 15.4. Blood Access Catheter (Non-tunneled) -- References -- 16. Anticoagulants / Toshihiro Torato -- 16.1. Introduction -- 16.2. Characteristics of Anticoagulants -- 16.3. Monitoring Anticoagulant Therapy -- 16.4. How to Use and Choose Anticoagulants -- 16.5. Summary -- References -- pt. III Complications -- 17. Hypotension / Tsuyoshi Inoue -- 17.1. Introduction -- 17.2. Cause and Etiology of Hypotension -- 17.3. How to Handle Hypotension During Apheresis Treatment -- 17.4. Safety Precautions -- References -- 18. Bleeding Complications and Reduction of Coagulation Factors / Norio Hanafusa -- 18.1. Introduction -- 18.2. Use of Anticoagulants -- 18.3. Removal of Coagulation Factors -- 18.4. Bleeding Complications due to Primary Diseases -- References -- 19. Allergies / Motonobu Nakamura -- 19.1. Introduction -- 19.2. Plasma Exchange -- 19.3. Therapeutic Sorption (Blood Adsorption and Plasma Absorption) -- 19.4. Anticoagulant Agents -- 19.5. Treatment for Allergic Reaction -- 19.6. Prophylaxes of Allergic Reactions -- References -- 20. Electrolyte Disorders / Motonobu Nakamura -- 20.1. Introduction -- 20.2. Calcium -- 20.3. Sodium -- 20.4. Acid--Base Balance -- 20.5. Potassium -- 20.6. Phosphate -- References -- 21. Avoiding Complications During Apheresis / Hiroko Yamamoto -- 21.1. Introduction -- 21.2. Complications Associated with Apheresis Equipment -- 21.3. Complications Associated with the Apheresis Treatment -- Reference -- 22. Infections / Osamu Yamazaki -- 22.1. Catheter-Related Bacteremia -- 22.2. Transfusion-Transmitted Infection with Fresh Frozen Plasma -- 22.3. Removal of Immunoglobulins due to Plasma Exchange -- References -- pt. IV Autoimmune Disorders -- 23. Neurological Diseases / Kousuke Negishi -- 23.1. General Principles -- 23.2. Myasthenia Gravis (MG) -- 23.3. Lambert-Eaton Myasthenic Syndrome -- 23.4. Guillain-Barre Syndrome -- 23.5. Chronic Inflammatory Demyelinating Polyneuropathy -- 23.6. Multiple Sclerosis -- References -- 24. Dermatological Disorders / Kousuke Negishi -- 24.1. Pemphigus and Pemphigoid -- 24.2. Steven-Johnson Syndrome and Toxic Epidermal Necrolysis -- References -- 25. Kidney Diseases / Kousuke Negishi -- 25.1. Nephrotic Syndrome (NS) -- 25.2. Rapidly Progressive Glomerulonephritis (RPGN) -- References -- 26. Rheumatoid Arthritis and Collagen Diseases / Hiroko Kanda -- 26.1. Rheumatoid Arthritis -- 26.2. Malignant Rheumatoid Arthritis -- 26.3. Systemic Lupus Erythematosus -- 26.4. Antiphospholipid Syndrome -- 26.5. ANCA-Associated Vasculitis -- References -- 27. Blood Type Incompatible Pregnancies / Norio Hanafusa -- 27.1. Introduction -- 27.2. Target Conditions and Substances -- 27.3. Actual Clinical Practice -- 27.4. Points to Note -- References -- 28. Multiple Myeloma / Tsuyoshi Inoue -- 28.1. Introduction -- 28.2. Multiple Myeloma -- 28.3. Hyperviscosity Syndrome -- 28.4. Therapeutic Protocol -- 28.5. Safety Precaution -- References -- 29. Dilated Cardiomyopathy / Yoshifumi Hamasaki -- 29.1. Introduction -- 29.2. Pathogenesis of Dilated Cardiomyopathy and Target for Apheresis -- 29.3. Efficacy of Apheresis -- 29.4. Method of Apheresis for DCM -- References -- pt. V Pathogens with Large Molecular Weight -- 30. Low Density Lipoprotein Apheresis / Kent Doi -- 30.1. Introduction -- 30.2. Indication for LDL Apheresis -- 30.3. Devices and Methods of LDL Apheresis -- 30.4. Treatment Precaution -- References -- 31. Endotoxin Absorption Therapy / Kent Doi -- 31.1. Role of Endotoxin in Sepsis -- 31.2. Removal of Endotoxin -- 31.3. Effects of PMX Direct Hemoperfusion on Sepsis -- 31.4. Procedures of PMX Direct Hemoperfusion -- 31.5. Complications -- References -- pt |
| Summary |
This pocket-sized manual serves as a concise and ideal reference work for therapeutic approaches using apheresis. Covering both basic theory and clinical details to facilitate improved treatment and patient outcomes, the text considers a variety of diseases, including myasthenia gravis, multiple sclerosis, Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, nephrotic syndrome, TTP/TMA, dilated cardiomyopathy, and many other conditions. The book also reviews the growing trend toward adopting this unique therapy for a wide range of health management issues such as morbid obesity and/or type 2 diabetes, and for lowering LDL-cholesterol (cholesterol apheresis) in patients unresponsive to medication or lifestyle modification |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Online resource; title from PDF title page (SpringerLink, viewed November 18, 2013) |
| In |
Springer eBooks |
| Subject |
Hemapheresis -- Handbooks, manuals, etc
|
|
Biomedical engineering.
|
|
Blood Component Removal -- methods
|
|
biomedical engineering.
|
|
MEDICAL -- Pharmacology.
|
|
Médecine.
|
|
Hemapheresis
|
| Genre/Form |
handbooks.
|
|
Handbooks and manuals
|
|
Handbooks and manuals.
|
|
Guides et manuels.
|
| Form |
Electronic book
|
| Author |
Noiri, E. (Eisei), editor.
|
|
Hanafusa, Norio, editor
|
| ISBN |
9784431544128 |
|
4431544127 |
|
4431544119 |
|
9784431544111 |
|
